fig3

Cutaneous toxicities of targeted therapies in the treatment of hepatocellular carcinoma

Figure 3. Subungual splinter hemorrhages in a patient on Sorafenib. Reprinted from Ishak et al.[33]

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/